SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018805
Filing Date
2024-05-13
Accepted
2024-05-13 09:00:44
Documents
34
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 311741
2 ex31-1.htm EX-31.1 11791
3 ex31-2.htm EX-31.2 11619
4 ex32-1.htm EX-32.1 5904
5 ex32-2.htm EX-32.2 5940
  Complete submission text file 0001493152-24-018805.txt   1631507

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inti-20240331.xsd EX-101.SCH 10921
7 XBRL CALCULATION FILE inti-20240331_cal.xml EX-101.CAL 19066
8 XBRL DEFINITION FILE inti-20240331_def.xml EX-101.DEF 48340
9 XBRL LABEL FILE inti-20240331_lab.xml EX-101.LAB 120236
10 XBRL PRESENTATION FILE inti-20240331_pre.xml EX-101.PRE 91985
37 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 121526
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 24937105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)